- ►annals.org RM Selik, SY Chu, JW Ward - Annals of internal medicine, 1995 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Objective: To determine trends in the relative frequency of infectious ... Cited by 111 - Related articles - BL Direct - All 4 versions
- ►annals.org RD Moore, RE Chaisson - Annals of internal medicine, 1996 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Objective: To determine the effect of contemporary clinical care on the ... Cited by 211 - Related articles - BL Direct - All 6 versions
AJ Saah, DR Hoover, Y Peng, JP Phair, B … - Jama, 1995 - Am Med Assoc OBJECTIVE--To identify clinical and epidemiological factors associated with
failure of Pneumocystis carinii pneumonia (PCP) prophylaxis in those receiving
primary and secondary prophylaxis. DESIGN--Longitudinal cohort study of ... Cited by 73 - Related articles - BL Direct - All 3 versions
DH Shepp, JE Moses, MH Kaplan - JAIDS Journal of Acquired Immune Deficiency …, 1996 - journals.lww.com Summary: To determine the prevalence and effect of cytomegalovirus (CMV)
co-infection on clinical outcome, the seroepidemiology of CMV was examined in
196 demographically diverse patients with advanced HIV disease. Thirty-six ... Cited by 27 - Related articles - BL Direct - All 3 versions
J Manischewitz, H Golding, B Baird, M De … - International Conference on AIDS, 1996 - gateway.nlm.nih.gov OBJECTIVE: To evaluate the anti-CMV activity of foscarnet (fos) in patients on a
clinical trial for the treatment of non-sight threatening CMV retinitis.
METHODS: A randomized controlled clinical trial was conducted in AIDS ... Cited by 5 - Related articles - Cached - All 2 versions
[CITATION] cols. A randomized, controlled study of cidofovir (CDV) for relapsing cytomegalovirus …
J Lalezari, G Holland, R Stagg - Program and Abstracts-35th Interscience Conference …, 2002 Cited by 5 - Related articles
[CITATION] cols. 1263W94-A novel, potent, orally bioavailable compound for the treatment of CMV. …
K Biron, RJ Harvey, M Davis - A symposium on antiviral treatment for HIV infection. …, 2002 Cited by 5 - Related articles
[CITATION] Prognosis value of quantitative of human cytomegalovirus (HCMV) leucocytic pp65 …
P Hazera, R Morello, A Vabret, R Verdon, F … - 4th Conference on Retroviruses and Opportunistic …, 2003 Cited by 5 - Related articles
[CITATION] cols. A pilot study to determine the efficacy of cytomegalovirus immune globulin (CMVIG-IV) …
MA Polis, G Kelly, J Manischevitz - 31st Annual Meeting of the Infectious Diseases …, 2004 Cited by 5 - Related articles
[CITATION] cols. Clinical manifestations of AIDS in the era of Pneumocystis prophylaxis. Multicenter …
